Live Breaking News & Updates on University Hospitals Gasthuisberg

Stay updated with breaking news from University hospitals gasthuisberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Nearly half of patients with giant cell arteritis achieve remission with upadacitinib

Nearly half of patients with giant cell arteritis achieve remission with upadacitinib
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Region Flamande , Shenaz Bagha , Daniel Blockmans , Kori Wallace , University Hospitals Gasthuisberg ,

Upadacitinib Looks Promising for Patients With Giant Cell Arteritis

The phase 3 SELECT-GCA study evaluated the efficacy and safety of upadacitinib in patients 50 years of age and older with GCA. ....

Region Flamande , Daniel Blockmans , University Hospitals Gasthuisberg , General Internal Medicine ,

AbbVie (ABBV) Reports Phase 3 SELECT-GCA Study of Upadacitinib Showed Positive Results in Patients With Giant Cell Arteritis

AbbVie (ABBV) Reports Phase 3 SELECT-GCA Study of Upadacitinib Showed Positive Results in Patients With Giant Cell Arteritis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Region Flamande , Daniel Blockmans , Kori Wallace , University Hospitals Gasthuisberg , General Internal Medicine ,

Phase 3 Upadacitinib Study Achieves Positive Results for the Treatment of Giant Cell Arteritis

Results of the SELECT-GCA study demonstrated approximately half of patients with giant cell arteritis treated with upadacitinib plus a steroid tapering regimen were able to achieve sustained remission through week 52. ....

Region Flamande , Daniel Blockmans , Kori Wallace , Medicine At University Hospitals Gasthuisberg , General Internal Medicine , University Hospitals Gasthuisberg ,

Cantargia AB: Cantargia to host R&D Day on new clinical results of nadunolimab in pancreatic cancer on April 24, 2023

LUND, Sweden, April 4, 2023 /PRNewswire/ Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced it will host an R&D Day focusing on new clinical results and biomarker data for ....

Region Flamande , David Liberg , Van Cutsem , Dominique Tersago , Eric Van Cutsem , Prnewswire Cantargia , University Hospitals Gasthuisberg , Vp Research , University Of Warsaw , Belgian Foundation , Nasdaq Stockholm , Division Head , Digestive Oncology , Eric Van , Medical University , Prof Van Cutsem , Belgian Royal Academy ,